These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 185524)

  • 81. Immune reactivity of RBL-3, a nonproducer leukemia induced by Rauscher murine leukemia virus in C57BL/6 mice.
    Chang KS
    J Natl Cancer Inst; 1978 Jul; 61(1):107-12. PubMed ID: 276620
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Immunologic characterization of sarcomas artificially infected with Graffi leukemia virus. II. Studies on the differentiation between viral and new cellular antigens].
    Pasternak L; Pasternak G
    Arch Geschwulstforsch; 1968; 32(4):301-8. PubMed ID: 4308111
    [No Abstract]   [Full Text] [Related]  

  • 83. Rauscher leukemia virus-induced tumor antigens: complete separation from gp70, p30 and H-2.
    Alaba O; Rogers MJ; Law LW
    Int J Cancer; 1979 Nov; 24(5):608-15. PubMed ID: 93583
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Quantitative study of the histocompatibility antigens on the surface of normal and leukaemic cells in mice. II. Quantitative variation in the expression of various H-2 specificities on the lymphoid cells from the B10 coisogenic strains of mice and their hybrids.
    Motta R; Phalente L; Le Doucen C
    Transplantation; 1974 Aug; 18(2):172-9. PubMed ID: 4136165
    [No Abstract]   [Full Text] [Related]  

  • 85. Cytotoxic activities of monoclonal antibodies against the envelope proteins of murine leukemia virus.
    Tam MR; Green WR; Nowinski RC
    Cancer Res; 1980 Oct; 40(10):3850-3. PubMed ID: 6254643
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Participation of soluble H-2 antigens in serological and cellular reactions].
    Pletneva TP; Kaulen DR; Khorobrykh VV; Kirkin AF; Kotomina IF
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1979; (5):24-8. PubMed ID: 88233
    [No Abstract]   [Full Text] [Related]  

  • 87. Susceptibility of anti-H-2-capped target cells to humoral and T lymphocyte-mediated lysis.
    Stulting RD; Todd RF; Gooding LR
    Transplantation; 1976 Jan; 21(1):71-3. PubMed ID: 1082189
    [No Abstract]   [Full Text] [Related]  

  • 88. Induction and specificity of syngeneic antiserum against Rauscher murine leukemia virus-induced leukemia, RBL-5.
    Alaba O; Law LW
    Int J Cancer; 1980 Aug; 26(2):217-25. PubMed ID: 7203714
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cell-mediated immunity to leukemia associated antigens in experimental models and in man.
    Herberman RB
    Hamatol Bluttransfus; 1976; 19():195-206. PubMed ID: 188727
    [No Abstract]   [Full Text] [Related]  

  • 90. Effect of inhibitors of macromolecular synthesis on HL-A antibody mediated lysis of cultured lymphoblasts.
    Ferrone S; Pellegrino MA; Dierich MP; Reisfeld RA
    Tissue Antigens; 1974; 4(4):275-82. PubMed ID: 4528542
    [No Abstract]   [Full Text] [Related]  

  • 91. Immunotherapy of mouse leukemia with monoclonal antibodies directed against type-C virus structural proteins.
    Boiocchi M; Mondellini P
    Tumori; 1984 Feb; 70(1):9-16. PubMed ID: 6324432
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Lymphocytotoxic antibodies produced by H-2 allo-immunisation distinguish between MuLV-positive and -negative substrains of the same H-2 haplotype.
    Ivanyi P; Melief CJ; van Mourik P; Vlug A; de Greeve P
    Nature; 1979 Dec 20-27; 282(5741):843-5. PubMed ID: 229425
    [No Abstract]   [Full Text] [Related]  

  • 93. Mouse fetal antigens in Rauscher leukemia.
    Ishimoto A; Suzuki Y; Yoshida T; Ito Y
    Bibl Haematol; 1975; (40):311-7. PubMed ID: 1164400
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Hemagglutination studies of the viral antigen in a murine leukemia (Rauscher).
    Sibal LR; Fink MA; Vice JL; Brandt BL; O'Connor TE
    Proc Soc Exp Biol Med; 1966 Jun; 122(2):591-6. PubMed ID: 4962939
    [No Abstract]   [Full Text] [Related]  

  • 95. Expression of tumor associated antigens by a producer and a nonproducer leukemia induced by Rauscher virus (R-MuLV).
    Chang KS; Liu W
    Cell Immunol; 1979 Feb; 42(2):373-83. PubMed ID: 427880
    [No Abstract]   [Full Text] [Related]  

  • 96. Role of the major histocompatibility complex in resistance to viral leukemia; its effect on the preleukemic stage of leukemogenesis.
    Lonai P; Katz E; Haran-Ghera N
    Springer Semin Immunopathol; 1982; 4(4):373-96. PubMed ID: 6293111
    [No Abstract]   [Full Text] [Related]  

  • 97. Phenotypic suppression of H-2 antigens and topography of the cell surface.
    Lengerová A; Pokorná Z; Viklický V; Zelený V
    Tissue Antigens; 1972; 2(4):332-40. PubMed ID: 4586482
    [No Abstract]   [Full Text] [Related]  

  • 98. Cell-surface antigens of murine sarcoma-virus-transformed non-producer cells: further evidence for lack of transplantation immunity.
    Greenberger JS; Stephenson JR; Aoki T; Aaronson SA
    Int J Cancer; 1974 Aug; 14(2):145-52. PubMed ID: 4376511
    [No Abstract]   [Full Text] [Related]  

  • 99. Characterization and partial purification of normal and tumor associated transplantation antigens of Rauscher leukemia cells.
    Martyré MC; Halle-Pannenko O; Jollès P
    Eur J Cancer (1965); 1973 Oct; 9(10):757-61. PubMed ID: 4803219
    [No Abstract]   [Full Text] [Related]  

  • 100. Molecular relationship between H-2 and ML antigens on leukaemia L-1210/v cells.
    Strzadala L; Steuden J; Radzikowski C
    J Immunogenet; 1977 Feb; 4(1):29-33. PubMed ID: 67154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.